uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NYSE NYSE · RVTY

Revvity

$124.31 +$3.47 +2.79% CLOSE 09.11.26 AFTER HOURS $124.31

Convergence score

3.1 / 5.0 NEUTRAL

+0.0 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$122.65 -1.3%

Range $90.00 — $165.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

3.1

/ 5.0

NEUTRAL

Consensus signal A

3.0

Consensus signal B

3.0

Consensus signal D

3.0

Analyst average

3.6

Multi-signal aggregate How CSR works →

Day Range

$121.66 – $124.65

52W Range

$81.22 – $133.00

Volume

1.2M

Avg Vol

1.5M

Mkt Cap

$13.87B

P/E

59.76

EPS (TTM)

$2.08

Div Yield

0.23%

Beta

1.09

Today's convergence

Convergence score sits at 3.1 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

NEUTRAL

Last close

$124.31

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$117-6.2% Hold

Long term

12–36 MO

$94.72-23.8% Overvalued

Open valuation →

Analysts

Coverage & consensus

5 PANELS

Mean target (12mo)

$122.65 -1.3%

RANGE $90.00 — $165.00

Analyst consensus

Consensus rating Hold

Blended score 3.3 / 5

Analysts tracked 97

Open analysts →

Financials

Key metrics

LATEST

P/E

59.76

EPS (TTM)

$2.08

Mkt Cap

$13.87B

Div Yield

0.23%

Beta

1.09

52W Range

$81.22 – $133.00

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Hold

Consensus target

$117 -6.2%

RANGE $90 – $165

$90NOW $124.31$165

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$94.72 -23.8%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 59.76	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $604.99M	PB Ratio: -	PS Ratio: -	Dividend: $0.07

Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Hold 3.3 5 97

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $90.00 $122.65 $125.00 $165.00 -1.3%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 0 10 27 0 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

9/9/2026

Firm

UBS Group

Action

Initiated Coverage

Rating

Buy ➝ Neutral

Target

$140.00

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$120.94

Open

$122.40

Day Low

$121.66

Day High

$124.65

Bid

$124.25

Ask

$123.95

52W Low

$81.22

52W High

$133.00

50D Avg

$117.12

200D Avg

$102.83

Volume

1.2M

Avg Vol

1.5M

10D Avg Vol

1.8M

52W Change

45.94%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

59.76

P/E (Fwd)

21.10

PEG (Fwd)

0.73

P/S

4.76

P/B

1.92

Book Value

$64.78

EV/Revenue

5.56

EV/EBITDA

18.48

Mkt Cap

13.87B

Enterprise Val

16.19B

Profitability & returns 6 FIELDS

Profit Margin

8.16%

Gross Margin

54.98%

Operating Margin

17.05%

EBITDA Margin

30.08%

Return on Assets

2.37%

Return on Equity

3.21%

Growth 3 FIELDS

Revenue Growth (YoY)

1.30%

Earnings Growth (YoY)

1.20%

Earnings Growth (Q)

-3.90%

Balance sheet & cash flow 11 FIELDS

Total Revenue

2.91B

EBITDA

875.83M

Total Cash

1.02B

Total Debt

3.34B

Cash / Share

$9.17

Revenue / Share

$25.77

Free Cash Flow

604.99M

Operating CF

627.63M

Debt / Equity

46.23

Current Ratio

1.80

Quick Ratio

1.36

Dividend 5 FIELDS

Fwd Dividend

0.28 (0.23%)

Dividend Yield

0.23%

Payout Ratio

13.46%

5Y Avg Yield

0.24%

Ex-Div Date

2026-10-23

Share statistics 7 FIELDS

Shares Out

111.59M

Float

102.49M

Shares Short

6.31M

% Short of Float

8.47%

Short Ratio

4.14

% Held Insiders

0.27%

% Held Institutions

96.53%

Calendar & events 5 FIELDS

Next Earnings

2026-10-26

Fiscal Year End

2025-12-28

Most Recent Qtr

2026-07-05

Last Split

2:1

Split Date

2001-06-04

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

11,000